Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: France Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20064
20073
20083
20092
20103
20113
20122
20163
20172
20222
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi5
Eli Lilly and Company4
H. Lundbeck A/S4
Janssen Research & Development, LLC4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AstraZeneca3
Neumora Therapeutics, Inc.2
Pfizer2
Takeda2
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder36
Depressive Disorder9
Mood Disorders6
Mental Disorders5
Anhedonia2
Sleep Initiation and Maintenance Disorders2
Dysthymic Disorder1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.